Amygdala Memory Enhancement

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Sep 22, 2021

Keywords

ClinConnect Summary

The "Amygdala Memory Enhancement" clinical trial is studying how the brain's amygdala, a region involved in emotions and memory, affects other parts of the brain to help us remember things better. This research is important for people with memory-related issues, including those with epilepsy, traumatic brain injuries, or post-traumatic stress disorder (PTSD). The goal is to learn how the amygdala can help prioritize long-term memories, which could lead to new treatments for these conditions.

To participate in this trial, you need to be between 65 and 74 years old and have been diagnosed with epilepsy. You should also be scheduled for a procedure that involves placing electrodes in specific parts of your brain to monitor seizures. It's important that you can speak and understand English and are able to give your consent to join the study. If you qualify, you can expect to be involved in long-term monitoring, which will provide valuable information that could help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Must be able to understand and speak English.
• • Able to provide informed consent.
• • Diagnosed with epilepsy.
• • Scheduled to undergo long-term intra-cranial video monitoring for seizure onset localization.
• • Must be implanted with intracranial depth electrodes to the left or right amygdala, hippocampus, and parahippocampal/perirhinal cortices.
• Exclusion Criteria:
• • Unable to understand and speak English.
• • Unable to provide informed consent.
• • Not diagnosed with epilepsy.